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ABSTRACT: Introduction: The Amyotrophic Lateral Sclerosis
(ALS)-Specific Quality of Life instrument and its revised version
(ALSSQOL and ALSSQOL-R) have strong psychometric proper-
ties, and have demonstrated research and clinical utility. In this
study we aimed to develop a short form (ALSSQOL-SF) suitable
for limited clinic time and patient stamina. Methods: The
ALSSQOL-SF was created using Item Response Theory and con-
firmatory factor analysis on 389 patients. A cross-validation sample
of 162 patients assessed convergent, divergent, and construct
validity of the ALSSQOL-SF compared with psychosocial and
physical functioning measures. Results: The ALSSQOL-SF con-
sisted of 20 items. Compared with the ALSSQOL-R, optimal preci-
sion was retained, and completion time was reduced from 15–25
minutes to 2–4 minutes. Psychometric properties for the
ALSSQOL-SF and its subscales were strong. Discussion: The
ALSSQOL-SF is a disease-specific global QOL instrument that has
a short administration time suitable for clinical use, and can provide
clinically useful, valid information about persons with ALS.
Muscle Nerve 58:646–654, 2018
Quality of life (QOL) is a broad term with many
operational definitions. Health-related QOL, or
health status, is most commonly used to describe an
individual’s perception of their well-being secondary
to their physical and mental functioning.1,2 However,
QOL is often conceived more broadly as being
impacted by many factors other than the physical or
mental health domains, such as family and friends,
finances, religion and spirituality, and existential
concerns.3 When defined in this manner, overall
QOL in patients with amyotrophic lateral sclerosis
(ALS) does not correlate with physical function and
appears to be maintained over time as physical func-
tion declines.4–10 Baseline and ongoing assessments
provide insight into factors that impact QOL, and
they may guide multidisciplinary interventions for
ALS patients. One instrument that captures this
global self-perception of QOL is the 59-item ALS-
Specific Quality of Life Instrument (ALSSQOL). This
questionnaire, and its revised, shorter version, the
ALSSQOL-R, have been validated in multicenter
studies.11–13 The ALSSQOL-R is a 50-item (46 scored)
instrument that measures overall QOL with 6 subscales
(Negative Emotion, Interaction with People and the
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Environment, Intimacy, Religiosity, Physical Symp-
toms, and Bulbar Function) and an average total
QOL score. Every subscale consists of several items,
each of which is rated by the patient on a 0–10-point
Likert-type scale (0 = least desirable, 10 = most desir-
able). Average total QOL score is the average of all
items, ranging from 0 (worst QOL) to 10 (best QOL).
Completion of the ALSSQOL-R by persons with
ALS takes approximately 15–25 minutes by interview.
Fatigue may make an assessment of this length
highly taxing or burdensome for some patients, par-
ticularly in view of research showing that patients
already cite the length of visits as a negative feature
of the multidisciplinary ALS clinic.14 In addition, it
may be challenging for busy ALS clinic personnel to
find time to administer the questionnaire. In view of
the utility of the ALSSQOL-R and these limiting fac-
tors, we sought to develop and validate a shorter ver-
sion, the ALSSQOL–Short Form (ALSSQOL-SF).
METHODS
For all studies and phases, institutional review board (IRB)
approval was obtained from all participating institutions, and
all participants provided informed consent.
Phase 1: Creation of the ALSSQOL-SF Patients. Phase
1 was a cross-sectional study using data from a validation study
of the ALSSQOL-R collected between 2005 and 2008.13 All
participants had definite, probable, probable laboratory-sup-
ported, or possible ALS,15 were ≥ 18 years of age, and fluent
in English at the grade 6 level or higher. Patients were
excluded if a physician or psychologist at the center judged
them to have cognitive impairment sufficient to preclude the
granting of informed consent and participation in the study.
Item Response Theory Methodology. Item Response The-
ory (IRT) analyses were conducted to inform ways of shorten-
ing the ALSSQOL-R with minimal loss of information.16 IRT is
a test design, analysis, and scoring approach that utilizes statis-
tical modeling to distinguish between the characteristics of the
person from the characteristics of the items to which they
responded.16 IRT is useful in test construction by using item-
level information to identify items that best suit the purpose
for a given measure. In an IRT context, information is equiva-
lent to the concept of reliability in classical test theory, except
that it can vary. In IRT, the precision of an item or measure
depends on the location of the individual on the trait scale,
whereas reliability makes an assumption that error is constant.
Using IRT to build a measure involves defining the ideal infor-
mation function and then selecting items that best approxi-
mate that shape.17 In designing a short form, the ideal
information function is the information function for the origi-
nal form. Thus, IRT can be effective in creating a short form
that provides similar information across the trait scale.
To provide guidance about which items should be removed
from the ALSSQOL-R to create the ALSSQOL-SF, item param-
eters for each of the 6 subscales were estimated with the Modi-
fied Graded Response Model (M-GRM),18 using PARSCALE.19
The slope parameter (α) is an indicator of discrimination
power, the extent to which the item can distinguish between
individuals with low and high trait levels, whereas the location
parameter (β) indicates the targeted trait value.20 Items were
selected based on: (i) large α parameters; (ii) relevance to the
construct the item was intended to measure; and
(iii) contribution to the shape of the information function for
the particular subscale.
Confirmatory Factor Analysis. A confirmatory factor
analysis (CFA) was conducted with AMOS 2121 to test the fit
of the short form to the original factor structure to substanti-
ate construct validity. Using the retained items from the IRT
analysis, the hypothesized model was fit to the data using max-
imum likelihood estimation. Model data fit was analyzed using
the comparative fit index (CFI),22 the root-mean-square error
of approximation (RMSEA),23 and the standard root-mean-
square residual (SRMR). The literature suggests CFI >0.95,
RMSEA < 0.06, and SRMR < 0.08 for good fit and CFI >0.90,
RMSEA < 0.10, and SRMR < 0.10 for acceptable fit.22,24,25
Phase 2: Cross-Validation Sample. Once the ALSSQOL-
SF was created, a prospective study of ALS patients attending
10 multidisciplinary clinics was conducted to test its validity.
Inclusion and exclusion criteria were identical to those in
Phase 1. Study measures were completed on site via interviews
with patients by ALS clinic personnel who were part of the site
study team. Patient enrollment and data collection were per-
formed from January through December 2014.
Participants’ demographics and descriptive information
were recorded, including the ALS Functional Rating Scale–
Revised (ALSFRS-R).26 After completion of the ALSSQOL-SF,
participants completed the following measures to evaluate the
construct, convergent, and discriminant (divergent) validity of
the overall ALSSQOL-SF and its subscales. These measures
were selected to replicate previous methodology used for the
development of the ALSSQOL-R, and were determined to be
reliable and valid11,27–29: the McGill Quality of Life Single-Item
Score (MQOL-SIS),30 modified to assess QOL over the past
7 days, rather than 2 days, appears on the ALSSQOL-SF as the
first question, although scored separately. This measure was
used for testing of validity of the ALSSQOL-SF’s assessment of
global QOL. The World Health Organization Quality of Life
Instrument–Brief version (WHOQOL-BREF)31 domain scores
(Psychological, Social Relationships, Environment, Physical
Health) were compared with the ALSSQOL-SF Average Total
Score or to subscales as follows: Psychological domain was
compared with the Negative Emotion subscales; Social Rela-
tionships domain was compared with the Interaction with Peo-
ple and the Environment and Intimacy subscales (no specific
comparison measure of intimacy was used, because most mea-
sures require information from both partners); Environment
domain was compared with the Interaction with People and
the Environment subscale; and Physical Health domain was
compared with the Physical Symptoms subscale. The Idler
Index of Religiosity32 (IIR), used to evaluate the ALSSQOL-SF
Religiosity subscale, has 2 subscales—Public Religiousness and
Private Religiousness. The Satisfaction with Life Scale33
(SWLS) was included to evaluate the ALSSQOL-SF Interaction
with People and Their Environment subscale. The Center for
Epidemiological Studies–Depressed Mood Scale34 (CES-D)
was compared with the Negative Emotion subscale. The
18-item Brief Symptom Inventory35 (BSI) was also compared
with the Negative Emotion subscale.
Statistical Analyses. Descriptive statistics were conducted
using mean and frequency data. Some demographic data were
not completed by the participants, and were de-identified
before they could be retrieved, resulting in minor variation in
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sample size for demographic data. The primary analysis of
the study used CFA to verify the structure and content of the
ALSSQOL-SF. The relationships between subscales of the
ALSSQOL-SF and external measures of the same constructs
were evaluated using Pearson’s product-moment correlations.
Hierarchical linear regression was used to evaluate the sub-
scales’ ability to predict global QOL. All analyses were con-
ducted with SPSS (version 22.0)36 and AMOS.21 P < 0.05 was
considered significant. A minimal sample size of 200 was
determined to be sufficient to conduct IRT, and greater than
needed to achieve 0.80 power with a medium effect size and
α = 0.01 for all remaining analyses. Two hundred subjects is
considered a small but reasonable sample for IRT37; a larger
sample would have been more difficult to obtain from this
population within the planned time-frame of the study. The
most important factors in determining the appropriate sample
size for this analysis are dependent on how much information
could be extracted from the data, and for the standard error for
the estimated parameters for the information functions to show
that they had similar shapes. This was accomplished here.
RESULTS
Phase 1: Creation of the ALSSQOL-SF. There were
389 participants (59% men). Ages ranged from 27 to
88 (mean 61, SD 11) years. Duration of symptoms at
study enrollment averaged 39.7 months (SD 39.2
months, median 26 months, range 3–232 months;
N = 324). Length of time from diagnosis to study
enrollment averaged 21.5 months (SD 27.0 months,
median 12.5 months, range 0–223 months; N = 362).
ALSFRS-R scores (N = 385) ranged from 6 to
48 (mean 33.11, SD 8.0).
Table S1 (refer to Supplementary Material online)
presents the estimated α and β parameters for the
ALSSQOL-R. Figure 1 presents the final information
functions for each subscale. The findings across the
6 graphs indicate that the ALSSQOL-SF had slightly
greater imprecision compared with the ALSSQOL-R,
although this is to be expected given that the
ALSSQOL-SF has fewer items. Table 1 provides a
structural comparison between the original and
short form. Twenty items were retained, reducing
the length of the ALSSQOL-R by > 50%. The Physi-
cal Symptom subscale was altered the least, with only
1 item removed, given that any further reductions to
the original scale would have reduced reliability to
below acceptable levels. Negative Emotion and Inter-
action with People and the Environment subscales
were reduced the most.
For the CFA, the hypothesized model is displayed
in Figure 2, using the retained items from the IRT
analysis. The CFA results show the model fit to be
acceptable: χ2(164) = 527.20; P < 0.001; CFI = 0.876;
RMSEA = 0.076; and SRMR = 0.078. Table 2 shows
the factor loadings by item for the ALSSQOL-SF. All
items loaded onto their respective factors as sug-
gested by the model, supporting the same factor
structure as the original ALSSQOL-R. Correlations
between factors (Table 3) were mostly low, ranging
from 0.06 to 0.42, and were similar to results for the
ALSSQOL-R.13 Table 3 presents the intercorrelations
among factors on the ALSSQOL-SF. It shows that
the results of the original principal component anal-
ysis with orthogonal varimax rotation that was con-
ducted to reduce the ALSSQOL to the ALSSQOL-R
remained intact when the ALSSQOL-R was further
reduced to the ALSSQOL-SF. Thus, the individuality
of the factors remained intact, and the correlations
between subscales are generally low to not
significant.
A copy of the current version of the ALSSQOL-SF
is presented in the Supplementary Material (online).
Phase 2: Cross-Validation Sample. There were
162 participants. The majority were male (59.3%;
N = 96), with a mean age of 60.5 years
(SD 10.99 years, range 26–85 years; N = 154). The
mean ALSFRS-R score was 31.08 (SD 9.15, range
1–48, median 32). Time from symptom onset to data
collection averaged 35.6 months (SD 34 months,
median 27.5 months, range 4–273 months), and
duration of time from diagnosis to study entry aver-
aged 20.8 months (SD 30.2 months, median
13 months, range 0–253 months). Completion of the
ALSSQOL-SF required 2–4 minutes. One hundred
fifty-four patients completed all items on the
ALSSQOL-SF, and were included in the CFA without
imputation. Series-mean imputation was used for
missing items to allow more complete data for addi-
tional analyses.
Evaluation of the ALSSQOL-SF. The initial CFA
run estimated a negative error variance for item
12 and, as a result, the model was unable to con-
verge. A negative error variance may have been
caused by the small sample size,38 or a Heywood
case,39 as item 12 is an indicator variable for the Reli-
giosity factor, which is only comprised of 2 items.40 A
Heywood case means the factor is possibly not con-
tributing unique variance. However, the negative
error variance was not statistically different from
0 (P > 0.05). Thus, the negative value is most likely
due to sampling error as a deficiency in the model
and can safely be constrained to a non-negative value
to allow the model to converge. After constraining
the error variance for item 12 to 0, the model con-
verged with a similar fit to the previous CFA:
χ2(165) = 349.92; P < 0.001; CFI = 0.857; RMSEA =
0.083; and SRMR = 0.10.
ALSSQOL-SF Scores. The mean score of all
ALSSQOL-SF items (Average Total Score) was 6.5
(SD 1.1, range 3.7–9.4). Scores for subscales are pro-
vided in Table 4. Range of scores showed maximum
use of the scale (minimum 0, maximum 10) for most
of the subscales.
648 ALSSQOL-SF MUSCLE & NERVE November 2018
n
oita
mr
of
nI
n
oita
mr
of
nI
n
oita
mr
of
nI
In
fo
rm
at
io
n
In
fo
rm
at
io
n
In
fo
rm
at
io
n
Negative Emotion
15 ALSSQOLR 15
10 10
Short Form
5 5
Interaction
0
-3 -2 -1 0 1 2 3
Trait Level
0
-3 -2 -1 0 1 2 3
Trait Level
Intimacy
8
6
4
2
0
-3 -2 -1 0 1 2 3
Trait Level
Religiosity
25
20
15
10
5
0
-3 -2 -1 0 1 2 3
Trait Level
Physical Symptoms
4
Bulbar Function
8
3 6
2 4
1 2
0
-3 -2 -1 0 1 2 3
Trait Level
0
-3 -2 -1 0 1 2 3
Trait Level
FIGURE 1. Information functions by subscale for the ALS-Specific Quality of Life Instrument-Revised (ALSSQOL-R) and its short
form, the ALSSQOL-SF. In an Item Response Theory (IRT) context, information is the corollary to reliability and can be expressed
as the reciprocal of the standard error conditional for a particular trait level: I(θ) = 1 / SE(θ)2. Thus, more information indicates
more precision in measurement. In addition, trait level refers to an individual’s capacity (score) for the particular construct mea-
sured by the subscale, with 0 representing the average and higher numbers reflecting more characteristics relative to the data in
the sample. The ALSSQOL-SF has slightly greater imprecision compared to the ALSSQOL-R, but the information functions dis-
play a consistent pattern between both forms, maximizing accuracy at the same points along the trait scale. Interaction = Interac-
tion with People and the Environment.
Table 1. Structural comparison of ALS-Specific Quality of Life Instrument–Revised and Short Form
Scale ALSSQOL-R ALSSQOL-SF ALSSQOL-R reliability ALSSQOL-SF reliability
Negative Emotion 13 items (28%) 3 items (15%) 0.91 0.86
Interaction 11 items (24%) 4 items (20%) 0.87 0.80
Intimacy 7 items (15%) 4 items (20%) 0.81 0.82
Religiosity 4 items (9%) 2 items (10%) 0.92 0.89
Physical Symptoms 6 items (13%) 5 items (25%) 0.71 0.70
Bulbar Function 5 items (11%) 2 items (10%) 0.83 0.81
Reliability was measured using Cronbach’s α. ALSSQOL-R, ALS-Specific Quality of Life Instrument–Revised; ALSSQOL-SF, ALS-Specific Quality of Life
Instrument–Short Form; Interaction, Interaction with People and the Environment.
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Validity Testing. Correlations are reported in
Table 5 for the ALSSQOL-SF Average Total and Sub-
scale Scores as assessments of convergent, divergent,
and construct validity. The ALSSQOL-SF Average
Total Score and ALSFRS-R showed a significant,
moderate correlation. Moderate, positive, significant
correlations were found between the ALSSQOL-SF
Average Total Score and other measures of global
QOL, including MQOL-SIS and WHOQOL subscales
and SWLS. Hierarchical multiple regression con-
ducted using MQOL-SIS as the dependent variable,
and the subscales of the ALSSQOL-SF as the
FIGURE 2. Hypothesized second-order model of factorial structure for the ALS-Specific Quality of Life Instrument–Short Form (ALSSQOL-
SF). The items contributing to each of the 6 subscales of the ALSSQOL-SF are shown. Item numbers correspond to the specific items of the
ALSSQOL-SF (see Supplementary Material online for the complete questionnaire). QOL = ALSSQOL-SF; Negative = Negative Emotion;
Bulbar = Bulbar Function; Physical = Physical Symptoms; Interaction = Interaction with People and the Environment.
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independent variable revealed only 3 (Negative Emo-
tion, Interaction with People and the Environment,
and Physical Symptoms) of the 6 variables were sig-
nificant predictors of MQOL-SIS, accounting for
2.7%, 9.6%, and 7.8%, respectively [F
(3, 153) = 5.083, P = 0.026], and a total of 44.7% of
the variability. The β weights are presented in
Table S2 (online).
Correlations of the Negative Emotion subscale
with the Depression and Anxiety subscales of the
18-item BSI, CESD, and WHOQOL Psychological
domain, were moderate to small. Correlations
between Interaction with People and the Environ-
ment and the WHOQOL Social Relationships sub-
scale, WHOQOL Environment subscale, and SWLS
were significant, and moderate to small. No direct
measure of intimacy was used. However, the
ALSSQOL-SF Intimacy subscale and WHOQOL
Social Relationships correlated moderately. Strong,
positive, and significant relationships were found
between the Religiosity subscale and both the Public
Religiosity subscale of the IIR and the total/overall
IIR score.
When assessing correlations of the Physical Symp-
toms subscale, a positive, moderate correlation was
found with the total ALSFRS-R score. A closer compar-
ison of subscales of the ALSFRS-R shows significant
correlations among all, but most closely with ALSFRS-
R Fine Motor and ALSFRS-R Gross Motor Function-
ing, and less so with ALSFRS-R Speech and Respira-
tory. The relationship between the ALSSQOL-SF
Physical Symptoms and the WHOQOL Physical
domain was strong and positive. Bulbar Function dem-
onstrated strong, positive, and significant correlations
with the ALSFRS-R Speech subscale. The relationship
between this subscale and the ALSFRS-R Respiratory
subscale was significant, but weak. There was not a sig-
nificant correlation between the ALSSQOL-SF Bulbar
Function and the WHOQOL Physical domain.
Table 2. Confirmatory factor analysis: standardized loadings for the ALS Specific Quality of Life Instrument–Short Form
Short Form items NE IPE IN RE PS BF
10. I have been depressed 0.868
14. I have felt hopeless 0.737
15. I have felt sad 0.838
8. The world has been caring and responsive to my needs 0.737
9. I have felt supported 0.840
11. Relationships have been satisfying 0.629
16. I have enjoyed the beauty of my surroundings 0.592
17. My desire for emotional intimacy has been strong 0.787
18. I have shared emotional intimacy with others 0.762
19. My desire for physical intimacy has been strong 0.702
20. I have shared physical intimacy with others 0.674
12. My religion has been a source of strength/comfort to me 0.969
13. I consider myself to have been religious or spiritual 0.834
1. Pain 0.468
2. Fatigue 0.676
5. My Strength and Ability to Move 0.505
6. Sleep 0.528
7. I have felt physically terrible 0.649
3. Excessive saliva 0.946
4. Speaking 0.724
NE, Negative Emotion; IPE, Interaction with People and the Environment; IN, Intimacy; RE, Religiosity; PS, Physical Symptoms; BF, Bulbar Function.
Table 3. Correlations between factors on the ALS-Specific
Quality of Life Instrument–Short Form
IPE IN RE PS BF
Negative Emotion 0.33† 0.17† 0.11* 0.42† 0.06
IPE 0.30† 0.30† 0.22† 0.07
Intimacy 0.25† 0.06 0.08
Religiosity 0.06 −0.07
Physical Symptoms 0.11*
NE, Negative Emotion; IPE, Interaction with People and the Environment;
IN, Intimacy; RE, Religiosity; PS, Physical Symptoms; BF, Bulbar Function.
*P < 0.05.
†P < 0.001.
Table 4. Normative/Mean scores of quality of life in total patient
sample completing the ALS Specific Quality of Life Instrument–
Short Form
Measure Mean (SD) Range
MQOL-SIS (N = 162) 7.0 (2.1) 0–10
ALSSQOL-SF Average Total Score (N = 160) 6.5 (1.1) 3.7–9.3
ALSSQOL-SF NE (N = 161) 5.3 (1.2) 1.0–7.7
ALSSQOL-SF IPE (N = 161) 8.6 (1.4) 3.0–10.0
ALSSQOL-SF IN (N = 159) 6.7 (2.3) 0.0–10.0
ALSSQOL-SF RE (N = 162) 6.7 (3.5) 0.0–10.0
ALSSQOL-SF PS (N = 162) 5.3 (2.3) 0.0–10.0
ALSSQOL-SF BF (N = 162) 6.4 (3.2) 0.0–10.0
ALSSQOL-SF Total Score (N = 160) 130.1 (21.9) 74–187
MQOL-SIS, McGill Quality of Life Single Item Scale; ALSSQOL-SF,
ALS-Specific Quality of Life Instrument–Short Form; NE, Negative Emotion;
IPE, Interaction with People and the Environment; IN, Intimacy; RE, Religi-
osity; PS, Physical Symptoms; BF, Bulbar Function.
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DISCUSSION
The ALSSQOL-R was successfully modified to a
briefer version, the ALSSQOL-SF, while maintaining
the goal of being a valid, disease-specific QOL instru-
ment. The ALSSQOL-SF retains the value of reflect-
ing areas that patients volunteered as most
important to their QOL, thus potentially assisting
health-care professionals with intervention planning
and comprehensive interprofessional care. The new
short form contains less than half of the number of
items of previous versions, which shortened time to
completion from 15–25 minutes to 2–4 minutes.
The results of Phase 1 represent a vast improve-
ment of the model fit compared with the original
ALSSQOL-R.13 The improvement in fit may be due
to removal of items that measured different facets of
the constructs and/or partially measured other char-
acteristics, decreasing the efficiency of the scale. This
improvement resulted in information being maxi-
mized in similar regions as in the original form, con-
tributing to optimal precision with fewer items.
We chose to retain a 0–10 rating scale on the
ALSSQOL-SF for administration/scoring of the mea-
sure because it allows for more sensitivity to subtle
changes in clinical symptoms for individuals in a
treatment setting. It is also consistent with other
scales to which patients are accustomed, such as pain
scales. The IRT scoring was used for validation of the
measure, but is not implemented in regular use of
the measure. It is likely, however, that the
correlation between participant scores on both scales
would be close to a perfect correlation. Thus,
although there may be less precision in someone’s
category score, it leads to the same inference and
therefore maintains score validity. Future studies
could evaluate a reduction in scale from 0–10 to 0–5
for clinical and research utility.
The Negative Emotion and Interaction with Peo-
ple and the Environment subscales originally had
the most items compared with the other subscales.
They also had the greatest reduction in items, and
therefore, clinically, these domains lost the most
information. However, given that these were 2 of the
more stable subscales of the ALSSQOL-R, the short-
ened versions are sufficient for representing and
evaluating these constructs.
Phase 2 demonstrated that the ALSSQOL-SF and
its subscales have construct, convergent, and diver-
gent (discriminant) validity. The weak to moderate
correlations between the ALSQOL-SF Average Total
Score and general global measures of QOL suggest
that they measure related but not overlapping
constructs.
The significant, yet small to moderate correlations
between the Negative Emotion subscale and the
18-item BSI and CESD suggest that negative emotion
is more than just anxiety or depression for persons
with ALS, as previously identified.12 The Negative
Emotion subscale appears to be appropriate as a
brief screening tool, but additional evaluation of
Table 5. Correlations between ALS-Specific Quality of Life Instrument-Short Form subscales and measures to test convergent,
divergent, and construct validity (N = 162 unless otherwise noted)
Measures ATS NE IPE PS IN RE BF
ALSFRS-R Total 0.40† 0.48† 0.29†
Speech 0.17* 0.79†
Fine Motor 0.37† 0.06
Gross Motor 0.44† −0.04
Respiratory 0.34† 0.23†
MQOLSIS 0.34† 0.28† (N = 161) 0.28† (N = 161) 0.25† 0.10 (N = 159) 0.09 0.11
WHOQOL Physical 0.47† (N = 161) 0.60† (N = 161) 0.118 (N = 161)
WHOQOL Psychological 0.52† (N = 158) −0.37† (N = 157 0.27* (N = 155)
WHOQOL Social 0.57† (N = 160) 0.49† (N = 159) 0.42† (N = 157)
WHOQOL Environment 0.39† (N = 159) 0.37† (N = 158)
SWLS 0.44† (N = 161) 0.33† (N = 160) 0.37† (N = 160) 0.21* (N = 161) 0.28† (N = 158) 0.16*
(N = 161)
0.10 (N = 161)
CESD −0.38† (N = 160)
BSI-18 Depression −0.37† (N = 159)
BSI-18 Anxiety −0.29† (N = 159)
BSI-18 Somatization −0.13 (N = 159)
BSI-18 Total −0.33† (N = 159)
IIR Public 0.63† (N = 151)
IIR Private −0.21† (N = 161)
IIR Total 0.57† (N = 151)
ATS, ALSSQOL-SF Average Total Score; NE, Negative Emotion; IPE, Interaction with People and the Environment; IN, Intimacy; RE, Religiosity; PS, Physi-
cal Symptoms; BF, Bulbar Function; MQOLSIS, McGill Quality of Life Single Item Scale; WHOQOL, World Health Organization Quality of Life; SWLS, Satis-
faction with Life Scale; CESD, Center for Epidemiological Studies Depressed Mood Scale; BSI-18, 18-item Brief Symptom Inventory; IIR, Idler Index of
Religiosity.
*P < 0.05.
†P < 0.001.
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depressed mood, anxiety, coping, and adjustment
should be performed if scores on this subscale
are low.
The Interaction with People and the Environment
subscale represents social relationships and existen-
tial considerations such as one’s appraisal of and
reciprocal relationship with the environment. The
moderate to small correlations between this subscale
and the WHOQOL Social Relationships, WHOQOL
Environment, and SWLS verify the complexity of
these concepts, shedding additional light on topics
of importance to ALS patients.
The concept of intimacy is not directly assessed in
global or general QOL measures. Measuring inti-
macy in ALS patients and monitoring its change over
time may be an important route of intervention and
for problem-solving ways to bolster QOL in ALS
patients, as it can be achieved despite physical dys-
function and decline.
The Religiosity subscale suggests that engaging in
religious practices as part of a community may have
intrinsic and social benefits that contribute to overall
QOL. However, this does not mean that more is bet-
ter. Rather, the Religiosity subscale may allow for a
more comprehensive needs assessment and may give
insight as to whether referrals for religious support
are warranted if there is a concordant decline in
Religiosity and in the overall QOL or the Negative
Emotion subscale.
Concurrent validity of the ALSSQOL-SF Physical
Function subscale is supported by the strong, posi-
tive, and significant relationship between that scale
and the WHOQOL Physical domain, both of which
evaluate patients’ perceptions of physical function-
ing. The convergent and construct validity of the
ALSSQOL-SF Bulbar Function subscale was evident
via its correlations with the ALSFRS-R Speech sub-
scale, whereas the lack of correlations with the
ALSFRS-R Fine Motor and Gross Motor subscales
and the WHOQOL Physical domain demonstrate
appropriate divergent/discriminant validity. This
supports Bulbar Function and Physical Symptoms
remaining as 2 distinct subscales of the ALSSQOL-
SF. Earlier research has also supported this distinc-
tion, as verbal communication was found to be
closely related to QOL,41 whereas overall physical
function has often been shown to not correlate with
global QOL.
Comparison of ALSSQOL-SF to the ALSSQOL-R. In
evaluating the ALSSQOL-SF’s ability to predict vari-
ance in the global QOL measure, MQOL-SIS, the
hierarchical multiple regressions for each of the
2 ALSSQOL measures were similar but not the same.
Only 2 of the 3 predictors (Negative Emotion and
Physical Symptoms) were shared between the
2 instruments, and ALSSQOL-R’s more expansive
Negative Emotion subscale predicted 37% of the
global QOL in the study sample compared with
2.7% of the variance being accounted for by the
Negative Emotion subscale of the ALSSQOL-SF.
Comparisons of the 2 versions of the ALSSQOL fur-
ther validate the factor structure, and reflect the dif-
ferences in the information provided by each.
Comparisons of the 2 instruments also reveal that
the new measure has weaker correlations on sub-
scales with external measures,13 which is not surpris-
ing, given the reduction in items. This suggests that
the short form subscales may be less reliable stand-
alone measures of these constructs than the
ALSSQOL-R subscales. The 2 versions of the mea-
sure provide flexibility. For instance, clinicians may
choose to use the ALSSQOL-R for the initial evalua-
tion of patients, and conduct follow-up assessments
with the short form. Another option is to routinely
use the short form for screening and follow-ups, and
to administer the ALSSQOL-R subscales only when
concern is raised in a specific area. Researchers may
prefer the ALSSQOL-R, given its provision of more
information and sensitivity to subtle changes in
broadly assessed domains. The flexibility in choosing
the version is supported by the similar overall QOL
score obtained using the ALSSQOL-SF (6.5),
ALSSQOL-R (6.8), and ALSSQOL (7.1).11,13
There were methodological limitations to this
study. Patient samples were drawn from individuals
attending large ALS referral centers, and thus may
not be representative of the ALS patient population
as a whole, despite a similar age and gender distribu-
tion to that of the general ALS population.42,43 Data
from the 2 studies were collected at different time
periods, and it is possible that patient care or values
relating to QOL changed in the interval. The close
match of results from the ALSSQOL-R and
ALSSQOL-SF studies diminishes this concern. Our
studies collected data through interviews; clinics
adopting the ALSSQOL-SF may prefer to use
computer-based or hard-copy self-completion of the
instrument. Although our previous research showed
no difference in results based on administration
method,44 it is possible that clinics may find different
results using different administration methods.
Limitations also exist regarding measures selected
for assessment of validity. A more recent version of
the CESD was developed and released in 2004, but
few appropriate normal scores were available at the
time the current study was being developed. The IIR
only has 4 items, and therefore less variability,
despite evidence supporting its reliability and valid-
ity.32 Intimacy measures have been validated on
younger, healthy populations,45,46 or require com-
parison of dyad responses, which was not practical
for this research. Last, the items on the ALSSQOL,
and therefore the ALSSQOL-R and -SF, are
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distributed among several of the subscales, and
therefore the subscales are defined and compared
by the dominant concepts reflected; no existential
comparative measure was used.
In conclusion, for purposes of measuring QOL as
a holistic construct and understanding factors that
affect patients’ reports of QOL, the ALSSQOL-SF
appears to be an efficient, quickly administered
instrument with good psychometric properties. Clini-
cians and researchers should consider the advan-
tages and limitations of the ALSSQOL-R vs. the
ALSSQOL-SF when choosing one or the other for a
specific use. Guidelines for scoring and routine clini-
cal use of the ALSSQOL-SF will appear in a forth-
coming manual.
Ethical publication statement: We (the authors) con-
firm that we have read the Journal’s position on
issues involved in ethical publication and affirm that
this report is consistent with those guidelines.
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